IDEA Collider: Innovation & Asymmetric Learning in Pharma
IDEA Collider explores how asymmetric learning drives bold innovation in the pharmaceutical and life sciences industries. Hosted by Mike Rea, CEO of IDEA Pharma & Head of Strategy and Thought Leadership at SAI MedPartners, the podcast features conversations with top thinkers, scientists, and strategists who challenge the status quo to spark real progress in drug development, biotech, and healthcare.
Each episode dives into how organizations can make smarter decisions earlier, reimagine R&D, and unlock competitive advantage through differentiated thinking.
Questions We Explore
* What is asymmetric learning, and how does it fuel pharma innovation?
* Why do some organizations outpace others—and what can we learn from them?
* How can we overcome barriers to meaningful progress in healthcare?
* What’s broken in traditional innovation models—and how do we fix it?
🎧 Listen and subscribe on all major platforms.
- Update frequency
- every 15 days
- Average duration
- 49 minutes
- Episodes
- 59
- Years Active
- 2019 - 2025
Where Do Good Ideas Come from? With Steven Johnson
Welcome to another fantastic episode of the IDEA Collider│Asymmetric learning series with your host Mike Rea. In today’s episode, Mike interviews Steven Johnson, an author of 13 books, a TV host, and…
Sick Money: The Truth About The Global Pharmaceutical Industry With Billy Kenber
Welcome to another fantastic episode of the IDEA Collider│Pharma Book Club series with your host Mike Rea. Today we are joined by Billy Kenber, an investigative journalist at “The Times.” He talks ab…
IDEA Collider | Kabir Nath
Kabir Nath is President & CEO, Otsuka North America Pharmaceutical Business Throughout his career, Kabir has built bridges between cultures. His work has taken him across the globe, spanning 3 contin…
IDEA Collider | Pharma Book Club | Kat Arney
(Now also released in paperback: https://amzn.to/3lWjo2B)
Kat can be found at First Create The Media: and on Twitter: @Kat_Arney
Find out more about Rebel Cell here: https://www.rebelcellbook.com/a…
IDEA Collider | Susanne Schaffert, PhD
As President of Novartis Oncology, Susanne Schaffert is pursuing a bold strategy to reimagine the research, development and commercialization of innovative treatments that will help improve and exten…
IDEA Collider | Dan Skovronsky
Dan Skovronsky is the chief scientific officer of Eli Lilly and Company. He serves as senior vice president of science and technology and president of Lilly Research Laboratories. He also has respons…
IDEA Collider | Pharma Book Club | Brian Christian
With so much at stake in the application of AI/ Machine Learning to pharma, biotech and medicine, this wonderful book touches on biases, systems of learning, and the choices we have to make to proper…
IDEA Collider | Nick Wood, Benji Compston
Syn is an award winning music agency and creative solutio, providing music strategy, composition, sound design and sonic branding for advertising, cinema and television, as well as music supervision…
IDEA Collider | Riccardo Zacconi
Great interview with Riccardo on CNBC
Find out more about PTEN Research at https://www.ptenresearch.org
IDEA Collider | John Tsai, MD
Covering a wide variety of topics, with a special focus on Novartis as one of the best examples of a learning organisation in pharma. On cultures of innovation, 'unbossing', decision making and measu…
IDEA Collider | Andy Coravos and Jen Goldsack, The DiMe Society Playbook
A discussion of The Playbook, from DiMe Society, Digital Clinical Measures
Introducing the essential industry guide for successfully developing & deploying digital clinical measures across clinical r…
IDEA Collider | Carinne Brouillon, Edward Hæggström, Rob Scott | Pharma Innovation Summit
Carinne Brouillon is a Member of the Board of Managing Directors, with responsibility for the Human Pharma Business Unit
Professional milestones
- 2018 – 2019 Global Head of Therapeutic Areas, Boehring…
IDEA Collider | Defining and Measuring Innovation
IDEA Collider | Pharma Book Club | Lee Vinsel and Andrew L. Russell
ABOUT THE INNOVATION DELUSION
Innovation is the hottest buzzword in business. But what if our obsession with finding the next big thing has distracted us from the work that matters most? “The most im…
IDEA Collider | Dr Peter Bach
Peter B. Bach is a physician, epidemiologist, researcher, and respected healthcare policy expert whose work focuses on the cost and value of anticancer drugs. Dr. Bach is leading efforts to increase …
IDEA Collider | Jen Horonjeff
In conversation, discussing patient input into clinical programs, unmet need assessments, measurement and so much more.
Jen was diagnosed with juvenile arthritis as an infant and now has a laundry lis…
IDEA Collider | Pharma Book Club | Gerald Posner
From the Amazon description: Pharmaceutical breakthroughs such as antibiotics and vaccines rank among some of the greatest advancements in human history. Yet exorbitant prices for life-saving drugs,…
IDEA Collider | Daphne Zohar
PureTech Health is an advanced, clinical-stage biopharmaceutical company developing novel medicines targeting serious diseases that result from dysfunctions in the nervous, immune, and gastrointestin…
IDEA Collider | Pharma Book Club | Jane Metcalfe
25 Visions for the Future of Our Species
We now have the tools to transform ourselves and our species. Greater health and longevity, enhanced brains, and engineered fertility are in the works. What’s…